| Ticker | NAUT |
| Long Name | Nautilus Biotechnology, Inc. |
| Short Name | Nautilus Biotechnology, Inc. |
Biotech
Biotechnology
Business Profile
Health Care
Healthcare
Major Pharmaceuticals
NAUT
Russell 2000
Russell 3000
Stocks
US
Nautilus Biotechnology, Inc. (NAUT) Business Profile
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the human proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington. The company trades on NMS exchange. The company headquarter is located in Seattle, United States. The company was established in the 2016.